Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States

被引:8
作者
Su, Jun [1 ]
Bylsma, Lauren C. [2 ]
Jiang, Xiaohui [2 ]
Morales Arias, Jaime [1 ]
Jain, Nisha [1 ]
Nordyke, Robert J. [3 ]
机构
[1] Sanofi, 50 Binney St, Cambridge, MA 02142 USA
[2] EpidStrategies, Ann Arbor, MI USA
[3] Beta6 Consulting Grp, Los Angeles, CA USA
关键词
Disease burden; healthcare resource utilization; cold agglutinin disease; autoimmune hemolytic anemia; database analysis; BURDEN; ANEMIA; COSTS;
D O I
10.1080/13696998.2020.1764006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims: Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia associated with increased thromboembolism risk and early mortality. Healthcare resource utilization (HRU) in CAD has not been reported. We aimed to compare HRU of patients with CAD with a matched non-CAD cohort in the United States. Materials and methods: Patients with CAD were identified from 2006 to 2016 in the Optum-Humedica database using CAD terms in clinical notes and hematologist review. Patients were required to have Integrated Delivery Network records and >= 6 months' follow-up before and after the first CAD mention date (index date). Patients with CAD were matched to a non-CAD cohort based on demographics. Multivariate analyses assessed inpatient hospitalizations, outpatient visits, emergency room visits, and transfusion use between cohorts 6 months before and 12 months after the index date. Results: Of 814 patients with CAD, 410 met inclusion criteria and were matched to 3,390 patients without CAD. Mean age of patients with CAD was 68.0 years; approximately 62% were female. In the 12 months after the index date, mean inpatient hospitalizations (0.83 vs. 0.25), outpatient visits (17.26 vs. 6.77), emergency room visits (0.55 vs. 0.32), and transfusion days (1.05 vs. 0.05) were higher for patients with CAD than the matched non-CAD cohort (all p < .0001). Similarly, in the 6 months before the index date, patients with CAD had higher HRU than matched patients without CAD for all measures evaluated. Limitations: Results of this study are based on patient information from the Optum-Humedica database, which is limited to commercially insured patients and may not represent the overall CAD population. Conclusions: CAD places a substantial burden on patients and healthcare systems. In addition, the high HRU for patients with CAD observed in the 6 months before diagnosis indicates that disease awareness and better diagnostic practices may be needed.
引用
收藏
页码:902 / 907
页数:6
相关论文
共 50 条
  • [41] Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population
    Rice, J. Bradford
    White, Alan
    Lopez, Andrea
    Galebach, Philip
    Schepman, Patricia
    Popelar, Breanna
    Philbin, Michael
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (07) : 649 - 654
  • [42] Insomnia-related comorbidities and economic costs among a commercially insured population in the United States
    Pollack, Michael
    Seal, Brian
    Joish, Vijay N.
    Cziraky, Mark J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) : 1901 - 1911
  • [43] The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States
    Ogbomo, Adesuwa
    Tsang, Yuen
    Mallampati, Rajesh
    Panjabi, Sumeet
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06) : 608 - 616
  • [44] Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States
    Klinger, James R.
    Wu, Benjamin
    Morland, Kellie
    Classi, Peter
    Fiano, Ryan
    Grabich, Shannon
    [J]. RESPIRATORY MEDICINE, 2023, 219
  • [45] Healthcare Resource Utilization and Economic Burden of Prurigo Nodularis in the United States
    Kwatra, Shawn G.
    Das, Ashis K.
    Chang, Eunice
    Paydar, Caleb
    Bahloul, Donia
    Chen, Chao
    Thomas, Ryan B.
    [J]. DERMATOLOGY AND THERAPY, 2025, 15 (02) : 413 - 425
  • [46] Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States
    Faught, Edward
    Laliberte, Francois
    Wang, Zhixiao
    Barghout, Victoria
    Haider, Batool
    Lejeune, Dominique
    Germain, Guillaume
    Choi, Jiyoon
    Wagh, Aneesha
    Duh, Mei Sheng
    [J]. EPILEPSIA, 2017, 58 (10) : 1742 - 1748
  • [47] Healthcare Resource Utilization Among Patients With Activated PI3Kd Syndrome in the United States: A Real-world Assessment by Patient Age
    Harrington, Amanda
    Laliberte, Francois
    Germain, Guillaume
    Mahendran, Malena
    Urosevic, Ana
    Rider, Nicholas
    [J]. CLINICAL IMMUNOLOGY, 2023, 250 : 100 - 101
  • [48] Increased healthcare resource utilization in higher disease activity levels in initiators of TNF inhibitors among US rheumatoid arthritis patients
    Boytsov, Natalie
    Harrold, Leslie R.
    Mason, Marc A.
    Gaich, Carol L.
    Zhang, Xiang
    Larmore, Cynthia J.
    Rebello, Sabrina
    Araujo, Andre B.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (12) : 1959 - 1967
  • [49] Retrospective analysis of health and economic burden among commercially-insured individuals diagnosed with invasive meningococcal disease in the United States
    Herrera-Restrepo, Oscar
    Kwiatkowska, Marta
    Huse, Samuel
    Kocaata, Zeki
    Ganz, Michael L.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01) : 2436039
  • [50] Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population
    Beinvogl, Beate
    Palmer, Nathan
    Kohane, Isaac
    Nurko, Samuel
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (11)